Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) rose 0.1% on Tuesday . The stock traded as high as $2.83 and last traded at $2.8230. Approximately 2,659 shares traded hands during trading, a decline of 77% from the average daily volume of 11,653 shares. The stock had previously closed at $2.8202.
Medexus Pharmaceuticals Trading Up 0.1%
The firm’s fifty day moving average price is $2.74 and its two-hundred day moving average price is $2.30.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late?stage and marketed assets, then manages their regulatory approval and commercialization.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
